Antibody Treatment Trial
- All
- News
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
UK Scientists Trial Instant Immunity Antibody Drug Treatment For Covid
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
UK Begins Trials Of New Antibody Treatment For COVID-19
The UK on Monday began human trials of a new antibody treatment for patients hospitalised with COVID-19.
-
Astrazeneca Starts Trial Of COVID-19 Antibody Treatment
British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
UK Scientists Trial Instant Immunity Antibody Drug Treatment For Covid
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
UK Begins Trials Of New Antibody Treatment For COVID-19
The UK on Monday began human trials of a new antibody treatment for patients hospitalised with COVID-19.
-
Astrazeneca Starts Trial Of COVID-19 Antibody Treatment
British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
